In the October 20, 2010 issue of JAMA (the Journal of the American Medical Association) a study was published entitled “Estrogen Plus Progestin and Breast
In a press conference, the FDA admitted that no adverse event involving compounded bio-identical estriol has ever been reported. Research involving 15,000 women funded by